Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $2.46M | ﹤0.01% |
177,605
+2,600
| +1% | +$34.7K |
2016 Q1
17 quarters
|
|
|
PRTK
2077
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.46M | ﹤0.01% |
+470,508
| New | +$2.09M |
2020 Q2
0 quarters
|
|
2078
Cincinnati Financial
CINF
$25.4B
| $2.45M | ﹤0.01% |
38,300
-426,118
| -92% | -$28.1M |
2013 Q2
28 quarters
|
|
2079
Brinker International
EAT
$8.47B
| $2.45M | ﹤0.01% |
+102,100
| New | +$2.19M |
2020 Q2
0 quarters
|
|
2080
DELISTED
Synchronoss Technologies
SNCR
| $2.45M | ﹤0.01% |
77,000
-23,078
| -23% | -$636K |
2018 Q4
6 quarters
|
|
|
LORL
2081
DELISTED
Loral Space and Communications, Inc.
LORL
| $2.44M | ﹤0.01% |
125,100
+22,100
| +21% | +$414K |
2019 Q1
5 quarters
|
|
|
CTIC
2082
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.44M | ﹤0.01% |
2,103,792
+17,668
| +0.8% | +$18.7K |
2016 Q1
17 quarters
|
|
2083
DELISTED
Unity Biotechnology
UBX
| $2.44M | ﹤0.01% |
28,090
+13,650
| +95% | +$1.01M |
2019 Q4
2 quarters
|
|
2084
Frequency Electronics
FEIM
$812M
| $2.43M | ﹤0.01% |
266,033
+7,900
| +3% | +$71.5K |
2013 Q2
28 quarters
|
|
|
TESS
2085
DELISTED
Tessco Technologies Inc
TESS
| $2.43M | ﹤0.01% |
442,500
+5,500
| +1% | +$29.2K |
2013 Q2
28 quarters
|
|
2086
CTO Realty Growth
CTO
$779M
| $2.43M | ﹤0.01% |
226,934
+19,738
| +10% | +$218K |
2016 Q2
16 quarters
|
|
2087
Modine Manufacturing
MOD
$9.17B
| $2.43M | ﹤0.01% |
440,407
+107,098
| +32% | +$492K |
2015 Q2
20 quarters
|
|
2088
GrowGeneration
GRWG
$87.8M
| $2.42M | ﹤0.01% |
+353,400
| New | +$1.94M |
2020 Q2
0 quarters
|
|
2089
VanEck Semiconductor ETF
SMH
$71.7B
| $2.41M | ﹤0.01% |
+31,600
| New | +$2.17M |
2020 Q2
0 quarters
|
|
2090
State Street Blackstone Senior Loan ETF
SRLN
$5.39B
| $2.41M | ﹤0.01% |
+55,500
| New | +$2.35M |
2020 Q2
0 quarters
|
|
2091
Mustang Bio
MBIO
$2.86M
| $2.4M | ﹤0.01% |
1,008
-93
| -8% | -$217K |
2018 Q4
6 quarters
|
|
2092
DELISTED
MRC Global
MRC
| $2.4M | ﹤0.01% |
406,900
+68,141
| +20% | +$354K |
2019 Q3
3 quarters
|
|
2093
AmeriServ Financial
ASRV
$73.9M
| $2.4M | ﹤0.01% |
780,243
+9,026
| +1% | +$26.3K |
2013 Q2
28 quarters
|
|
2094
Nelnet
NNI
$4.54B
| $2.4M | ﹤0.01% |
+50,300
| New | +$2.35M |
2020 Q2
0 quarters
|
|
2095
Centrus Energy
LEU
$2.75B
| $2.4M | ﹤0.01% |
238,935
+132,900
| +125% | +$1.06M |
2019 Q2
4 quarters
|
|
2096
Ballard Power Systems
BLDP
$621M
| $2.4M | ﹤0.01% |
155,800
-140,613
| -47% | -$1.54M |
2020 Q1
1 quarter
|
|
2097
McEwen Inc
MUX
$1.04B
| $2.39M | ﹤0.01% |
236,970
+58,650
| +33% | +$545K |
2019 Q4
2 quarters
|
|
2098
ProShares Short 20+ Year Treasury ETF
TBF
$136M
| $2.39M | ﹤0.01% |
154,900
+106,300
| +219% | +$1.65M |
2018 Q4
6 quarters
|
|
2099
WidePoint Corp
WYY
$68.9M
| $2.38M | ﹤0.01% |
341,898
+187,181
| +121% | +$1M |
2016 Q3
15 quarters
|
|
2100
Dawson Geophysical
DWSN
$77.6M
| $2.38M | ﹤0.01% |
1,649,998
-14,384
| -0.9% | -$19.3K |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.